Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Acute and chronic antibody-mediated rejection in pediatric kidney transplantation.

Literature DB >> 24865478

Acute and chronic antibody-mediated rejection in pediatric kidney transplantation.

Lars Pape¹, Jan U Becker, Stephan Immenschuh, Thurid Ahlenstiel.

Abstract

Acute antibody-mediated rejection is a diagnostic challenge in renal transplantation medicine. However, it is an important diagnosis to make, since chronic antibody-mediated rejection (CAMR) is the main cause of long-term graft loss. Antibody-mediated rejection is diagnosed by detecting donor-specific antibodies (DSAs) in the blood in combination with observing typical histomorphological signs in kidney biopsy, as described in the Banff classification. Therapy is based on the removal of DSAs by administering intravenous immunoglobulins (IVIGs), plasmapheresis, or immunoadsorption. Reoccurrence of antibodies is diminished by the use of rituximab, increased immunosuppression, and in some cases additional experimental substances. A combination of these techniques has been shown to be successful in the majority of cases of acute and chronic antibody-mediated rejection. Routine DSA monitoring is warranted for early detection of antibody-mediated rejection.

Entities: Chemical Species

Mesh：

Substances：
Antibodies
HLA Antigens

Year: 2014 PMID： 24865478 DOI： 10.1007/s00467-014-2851-2

Source DB: PubMed Journal: Pediatr Nephrol ISSN： 0931-041X Impact factor: 3.714

64 in total

Review 1. Antibodies, isotypes and complement in allograft rejection.

Authors: Georg A Böhmig; Gregor Bartel; Markus Wahrmann
Journal: Curr Opin Organ Transplant Date: 2008-08 Impact factor: 2.640

2. Antibody-mediated rejection--an ounce of prevention is worth a pound of cure.

Authors: J A Bradley; W M Baldwin; A Bingaman; C Ellenrieder; H M Gebel; D Glotz; A D Kirk
Journal: Am J Transplant Date: 2011-06 Impact factor: 8.086

3. Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques.

Authors: A Piazza; E Poggi; L Borrelli; S Servetti; P I Monaco; O Buonomo; M Valeri; N Torlone; D Adorno; C U Casciani
Journal: Transplantation Date: 2001-04-27 Impact factor: 4.939

4. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?

Authors: Marta Crespo; Alberto Torio; Virginia Mas; Dolores Redondo; Maria J Pérez-Sáez; Marisa Mir; Anna Faura; Rita Guerra; Olga Montes-Ares; Maria D Checa; Julio Pascual
Journal: Transpl Immunol Date: 2013-07-29 Impact factor: 1.708

Review 5. Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients.

Authors: S C Jordan; M Toyoda; J Kahwaji; A A Vo
Journal: Am J Transplant Date: 2011-01-10 Impact factor: 8.086

6. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.

Authors: B Sis; M Mengel; M Haas; R B Colvin; P F Halloran; L C Racusen; K Solez; W M Baldwin; E R Bracamonte; V Broecker; F Cosio; A J Demetris; C Drachenberg; G Einecke; J Gloor; D Glotz; E Kraus; C Legendre; H Liapis; R B Mannon; B J Nankivell; V Nickeleit; J C Papadimitriou; P Randhawa; H Regele; K Renaudin; E R Rodriguez; D Seron; S Seshan; M Suthanthiran; B A Wasowska; A Zachary; A Zeevi
Journal: Am J Transplant Date: 2010-01-29 Impact factor: 8.086

7. National conference to assess antibody-mediated rejection in solid organ transplantation.

Authors: Steven K Takemoto; Adriana Zeevi; Sandy Feng; Robert B Colvin; Stanley Jordan; Jon Kobashigawa; Jerzy Kupiec-Weglinski; Arthur Matas; Robert A Montgomery; Peter Nickerson; Jeffrey L Platt; Hamid Rabb; Richard Thistlethwaite; Dolly Tyan; Francis L Delmonico
Journal: Am J Transplant Date: 2004-07 Impact factor: 8.086

8. Complement-binding anti-HLA antibodies and kidney-allograft survival.

Authors: Alexandre Loupy; Carmen Lefaucheur; Dewi Vernerey; Christof Prugger; Jean-Paul Duong van Huyen; Nuala Mooney; Caroline Suberbielle; Véronique Frémeaux-Bacchi; Arnaud Méjean; François Desgrandchamps; Dany Anglicheau; Dominique Nochy; Dominique Charron; Jean-Philippe Empana; Michel Delahousse; Christophe Legendre; Denis Glotz; Gary S Hill; Adriana Zeevi; Xavier Jouven
Journal: N Engl J Med Date: 2013-09-26 Impact factor: 91.245

9. Beyond histology: lowering human leukocyte antigen antibody to improve renal allograft survival in acute rejection.

Authors: Matthew J Everly; Lorita M Rebellato; Mikki Ozawa; Kimberly P Briley; Paul G Catrou; Carl E Haisch; Paul I Terasaki
Journal: Transplantation Date: 2010-04-27 Impact factor: 4.939

10. Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.

Authors: M Haas; B Sis; L C Racusen; K Solez; D Glotz; R B Colvin; M C R Castro; D S R David; E David-Neto; S M Bagnasco; L C Cendales; L D Cornell; A J Demetris; C B Drachenberg; C F Farver; A B Farris; I W Gibson; E Kraus; H Liapis; A Loupy; V Nickeleit; P Randhawa; E R Rodriguez; D Rush; R N Smith; C D Tan; W D Wallace; M Mengel
Journal: Am J Transplant Date: 2014-02 Impact factor: 8.086

5 in total

5. Cytokine Profiles in Children After Pediatric Kidney Transplantation With Acute Cellular Compared to Chronic Antibody-mediated Rejection and Stable Patients: A Pilot Study.

Authors: Nadja Borsum; Murielle Verboom; Thurid Ahlenstiel-Grunow; Lars Pape
Journal: Transplant Direct Date: 2019-10-08